Holen Sie sich die Stockscreener-App
40.80
2.38%
0.95
Handel nachbörslich:
41.24
0.44
+1.08%
Schlusskurs vom Vortag:
$39.85
Offen:
$40.25
24-Stunden-Volumen:
2.44M
Relative Volume:
1.01
Marktkapitalisierung:
$7.68B
Einnahmen:
$550.17M
Nettoeinkommen (Verlust:
$201.35M
KGV:
40.80
EPS:
1
Netto-Cashflow:
$232.07M
1W Leistung:
-0.61%
1M Leistung:
-9.29%
6M Leistung:
-31.29%
1J Leistung:
-27.18%
1-Tages-Spanne:
$39.99
$41.20
1-Wochen-Bereich:
$39.50
$42.13
52-Wochen-Spanne:
$39.50
$85.21
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Vergleichen Sie DOCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell - Yahoo Finance
Doximity (NASDAQ:DOCS) Hits New 12-Month LowHere's What Happened - MarketBeat
Doximity stock hits 52-week low at $39.92 amid challenging year - Investing.com Nigeria
Doximity stock hits 52-week low at $39.92 amid challenging year By Investing.com - Investing.com India
Wells Fargo & Company Upgrades Doximity (NYSE:DOCS) to Strong-Buy - MarketBeat
Doximity (NASDAQ:DOCS) Strengthens Professional Medical Networking - Kalkine Media
DOCS Analyst Rating Update: Wells Fargo Lowers Price Target | DO - GuruFocus
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - AOL.com
Assessing Doximity: Insights From 9 Financial Analysts - Benzinga
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino's Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - 24/7 Wall St.
Is It Time To Reconsider Doximity (DOCS) After Recent Share Price Weakness - Sahm
Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026 - 01net
Raymond James Sees 'Knee-Jerk' AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Finviz
Doximity (DOCS) Is Down 13.4% After Cutting 2026 Revenue Outlook Amid Regulatory PressuresWhat's Changed - Sahm
Raymond James Sees ‘Knee-Jerk’ AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Insider Monkey
Raymond James sees ‘knee-jerk’ AI reaction, reaffirms strong buy on Doximity, Inc. (DOCS) - MSN
Bandwidth, Dynatrace, Paylocity, Doximity, and Agilysys Stocks Trade Down, What You Need To Know - The Globe and Mail
RSI Alert: Doximity (DOCS) Now Oversold - Nasdaq
Redlands Daily Facts - FinancialContent
3 Reasons DOCS Has Explosive Upside Potential - Finviz
Is Doximity (DOCS) Pricing Reflect Its Mixed Valuation Signals After Recent Share Price Slide - Yahoo Finance
Doximity (DOCS) Declines More Than Market: Some Information for Investors - sharewise.com
Doximity (DOCS) declines more than market: Some information for investors - MSN
Winners Losers: Will Doximity Inc stock reach Wall Street targetsJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Here's Why Doximity (DOCS) is a Strong Growth Stock - sharewise.com
Doximity (NASDAQ:DOCS) Sets New 1-Year LowWhat's Next? - MarketBeat
Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More - AOL.com
Ad Vital Founder Dr. Shitel Patel Featured in Doximity For Expertise on Practice Sustainability - Digital Journal
Penticton Herald: FinanceDoximity (DOCS) Shares Hit 52-Week Low: Analyzing the Digital Health Downturn - FinancialContent
Doximity stock hits 52-week low at 43.17 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 43.17 USD - Investing.com
Doximity (DOCS) Slid on Renewed Volatility - Yahoo Finance
As layoff loomed, exec turned to insider trading - Investment Executive
Volatility Watch: Will Doximity Inc stock benefit from upcoming earnings reportsOptions Play & Safe Entry Trade Reports - Bộ Nội Vụ
InvestingPro’s Fair Value model predicted Doximity’s 41% stock decline By Investing.com - Investing.com UK
Doximity reaches $31M settlement in securities litigation lawsuit - MSN
Understanding Momentum Shifts in (DOCS) - Stock Traders Daily
Morgan Stanley views Doximity (DOCS) underperformance as attractive entry point amid strong engagement - MSN
Morgan Stanley Views Doximity (DOCS) Underperformance as Attractive Entry Point Amid Strong Engagement - Insider Monkey
Doximity, Inc. (NYSE:DOCS) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Doximity (NYSE:DOCS) Stock Rating Upgraded by The Goldman Sachs Group - MarketBeat
Doximity (NYSE:DOCS) Raised to "Strong-Buy" at Truist Financial - MarketBeat
Morgan Stanley Stays Neutral on Doximity, Highlights Strength in Video Module Business - MSN
Doximity (NYSE:DOCS) Stock Rating Lowered by Wall Street Zen - MarketBeat
Ex-Doximity Exec Cops To $2.5M Insider Trading Scheme - Law360
Doximity: RBC touts growth moat while Goldman sees valuation reset - Investing.com
Doximity's Double-Digit Growth Rate is Sustainable, RBC Says - marketscreener.com
Will Doximity’s (DOCS) AI Momentum and US$31 Million Settlement Shift Its Core Investment Narrative? - Yahoo Finance
Raymond James reiterates Strong Buy on Doximity stock amid AI competition - Investing.com Nigeria
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.16%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):